Collaboration in Times of Crisis: A Study on COVID-19 Vaccine R&D Partnerships

Research output: Contribution to journalJournal articleResearchpeer-review

This paper provides an empirical investigation into the types of partnerships that have emerged during the pandemic to develop COVID-19 vaccines and to identify relevant factors that characterize these partnerships. We provide legal and policy considerations to our results that suggest an opportunity for policymakers to help shift the collaborative landscape to increase the potential for knowledge-sharing, the development of fundamental insight, and the adequate production of resulting technological goods, both in this pandemic and the next.

Volume 39, Issue 42, 8 October 2021, Pages 6291-6295
Original languageEnglish
Issue number42
Pages (from-to)6291 - 6295
Number of pages5
Publication statusPublished - 8 Oct 2021

    Research areas

  • Faculty of Law - Legal considerations, Pharmaceutical policy, COVID-19, Vaccine, knowledge sharing, empirical legal studies, empirical research

ID: 276122727